Accelerating optical reporting for conformation of tyrosine kinase
inhibitors in solutions
Abstract
It has been a challenge in automated analysis of medical and chemical
knowledge to extract represent quantitative structure–activity
relationship (QSAR) using intelligent computing in drug discovery. One
of many domain-specific bottlenecks in drug discovery is robust
conformation search in three-dimensional (3D) space for flexible drug
candidates. The process involves researchers and machines working
together to achieve their own strengths for greater outcome. The present
study has been developing a method for conformational sampling
conformers in the class of 4-anilinoquinazoline derivatives for
epidermal growth factor receptor (EGFR) tyrosine kinases inhibitors
(TKIs). We use AG-1478 to demonstrate how the new intelligent computing
method helps to quantum mechanically determine 22 target drug conformer
clusters and their properties from conformational sampling, based on
density functional theory (DFT) method, time-dependent (TD)-DFT in
solvents and clustering analysis (CA). The UV-vis spectra of the
preferred conformers agree well with earlier experimental measurements
in which the conformer dependent UV-Vis spectral shift of AG-1478 can be
as large as approximately 15 nm. We are further developing this method
to study and design new 4-anilinoquinazoline derivatives of EGFR TKIs.